Laura Carter - Jun 30, 2021 Form 4 Insider Report for Gossamer Bio, Inc. (GOSS)

Role
Chief Scientific Officer
Signature
/s/ Jeff Boerneke, Attorney-in-Fact
Stock symbol
GOSS
Transactions as of
Jun 30, 2021
Transactions value $
$0
Form type
4
Date filed
7/1/2021, 04:02 PM
Next filing
Oct 26, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GOSS Common Stock Award $0 +25K +34.4% $0.00 97.7K Jun 30, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a restricted stock unit award, which will vest on the first anniversary of the grant date in accordance with the terms of the award and subject to the Reporting Person's continuous service to the Issuer on such vesting date.